CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase 1 Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT02561988
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:39:15.887476+00:00
- Published At
- 2023-03-17T00:00:00+00:00
- Record Updated At
- 2023-03-17
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Aggressive Systemic Mastocytosis", "Systemic Mastocytosis-associated Hematologic Non-mast Cell Disease", "Mast Cell Leukemia", "Relapsed or Refractory Myeloid Malignancies"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-03-17"- protocolSection.identificationModule.nctId
"NCT02561988"- protocolSection.identificationModule.officialTitle
"A Phase 1 Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.